A minimally invasive, outpatient treatment for Gastroesophageal Reflux Disease (GERD), resulting in permanent relief from both GERD symptoms and life-long drug dependency

Project description

Simple outpatient treatment for acid reflux disease

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drug
• medical and health sciences › clinical medicine › anaesthesiology
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › enzymes
• social sciences › economics and business › business and management › commerce

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

ASCENTX MEDICAL EUROPE LIMITED

Address

Unit 6 Queens Yard, White Post Lane
E95EN London
United Kingdom

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 50 000